[Oncogenic mechanisms of Epstein-Barr virus].
Herrero
J A
JA
Mayo Foundation, Rochester, Minnesota, USA.
D000956:Antigens, Viral / Q000378:metabolism; D002051:Burkitt Lymphoma / Q000821:virology; D006566:Herpesviridae Infections / Q000635:transmission; D004854:Herpesvirus 4, Human / Q000235:genetics / Q000378:metabolism / Q000472:pathogenicity* / Q000502:physiology; D006689:Hodgkin Disease / Q000821:virology; D006801:Humans; D016483:Lymphoma, AIDS-Related / Q000821:virology; D008232:Lymphoproliferative Disorders / Q000821:virology*; D009856:Oncogene Proteins, Viral / Q000378:metabolism; D016377:Organ Transplantation; D014412:Tumor Virus Infections / Q000635:transmission; D014763:Viral Matrix Proteins / Q000378:metabolism
D000956:Antigens, Viral; C037662:EBV-associated membrane antigen, Epstein-Barr virus; D009856:Oncogene Proteins, Viral; D014763:Viral Matrix Proteins